| PSA |
Report |
Core FFO/share |
BEAT |
pred ~$4.31 vs. cons $4.251 |
MEDIUM |
| PSA |
Report |
Same-store revenue growth |
BEAT |
pred ~-0.10% vs. cons -0.34% |
MEDIUM |
| PSA |
Report |
Same-store NOI growth |
BEAT |
pred ~-0.80% vs. cons -1.60% |
MEDIUM |
| PSA |
Guide |
Core FFO/share (FY26) |
LOWER |
guide ~$16.35-$17.00 vs. cons $16.94 |
MEDIUM |
| PSA |
Guide |
Same-store revenue growth (FY26) |
LOWER |
guide ~-2.2% to 0.0% vs. cons -0.15% |
MEDIUM |
| PSA |
Guide |
Same-store NOI growth (FY26) |
LOWER |
guide ~-3.9% to -0.5% vs. cons -0.56% |
MEDIUM |
| PSA |
Return |
Day-1 residual (stock − beta × S&P 500) |
-2.5% |
— |
LOW |
| PSA |
Return |
5-day cumulative residual |
-3.0% (FOLLOW-THROUGH) |
FOLLOW-THROUGH — maintained FY guide implies a 2H estimate cut |
LOW |